{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T06:05:54Z","timestamp":1749794754348},"reference-count":36,"publisher":"Japanese Society of Hypertension","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2007]]},"DOI":"10.1291\/hypres.30.979","type":"journal-article","created":{"date-parts":[[2007,11,30]],"date-time":"2007-11-30T05:51:21Z","timestamp":1196401881000},"page":"979-989","source":"Crossref","is-referenced-by-count":17,"title":["Aldosterone-and-Salt-Induced Cardiac Fibrosis Is Independent from Angiotensin II Type 1a Receptor Signaling in Mice"],"prefix":"10.1291","volume":"30","author":[{"given":"Shuntaro","family":"KAGIYAMA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"MATSUMURA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayo","family":"FUKUHARA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanae","family":"SAKAGAMI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"FUJII","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuo","family":"IIDA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"119","reference":[{"issue":"11\/12","key":"1","first-page":"859","volume":"14","year":"1987","ISSN":"http:\/\/id.crossref.org\/issn\/0305-1870","issn-type":"print"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Lomb&egrave;s M, Oblin ME, Gasc JM, Baulieu EE, Farman N, Bonvalet JP: Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor. <i>Circ Res<\/i> 1992; <b>71<\/b>: 503-510.","DOI":"10.1161\/01.RES.71.3.503"},{"issue":"1 Pt 1","key":"3","first-page":"45","volume":"29","year":"1997","ISSN":"http:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"4","unstructured":"4. Brilla CG, Weber KT: Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. <i>J Lab Clin Med<\/i> 1992; <b>120<\/b>: 893-901."},{"issue":"6 Pt 1","key":"5","first-page":"971","volume":"26","year":"1995","ISSN":"http:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Rocha R, Rudolph AE, Frierdich GE, <i>et al<\/i>: Aldosterone induces a vascular inflammatory phenotype in the rat heart. <i>Am J Physiol Heart Circ Physiol<\/i> 2002; <b>283<\/b>: H1802-H1810.","DOI":"10.1152\/ajpheart.01096.2001"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L, CONSENSUS Trial Study Group: Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. <i>Circulation<\/i> 1990; <b>82<\/b>: 1730-1736.","DOI":"10.1161\/01.CIR.82.5.1730"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Pitt B, Zannad F, Remme WJ, <i>et al<\/i>, Randomized Aldactone Evaluation Study Investigators: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. <i>N Engl J Med<\/i> 1999; <b>341<\/b>: 709-717.","DOI":"10.1056\/NEJM199909023411001"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"issue":"4","key":"10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.HYP.33.4.981","volume":"33","author":"ROBERT V","year":"1999","ISSN":"http:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"issue":"12","key":"11","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1139\/y85-250","volume":"63","year":"1985","ISSN":"http:\/\/id.crossref.org\/issn\/0008-4212","issn-type":"print"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000140771.21243.ed"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Mihailidou AS, Mardini M, Funder JW, Raison M: Mineralocorticoid and angiotensin receptor antagonism during hyperaldosteronemia. <i>Hypertension<\/i> 2002; <b>40<\/b>: 124-129.","DOI":"10.1161\/01.HYP.0000025904.23047.27"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000030181.63741.56"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000047104.42047.9B"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.925"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.29.169"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.08.056"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sam F, Xie Z, Ooi H, <i>et al<\/i>: Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion. <i>Am J Hypertens<\/i> 2004; <b>17<\/b>: 188-193.","DOI":"10.1016\/j.amjhyper.2003.10.007"},{"issue":"2","key":"20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/01.HYP.35.2.550","volume":"35","author":"OLIVERIO M I","year":"2000","ISSN":"http:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000159937.05502.d1"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000131860.80444.AB"},{"key":"23","unstructured":"23. Sun Y, Weber KT: Angiotensin II and aldosterone receptor binding in rat heart and kidney: response to chronic angiotensin II or aldosterone administration. <i>J Lab Clin Med<\/i> 1993; <b>122<\/b>: 404-411."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Bhargava A, Fullerton MJ, Myles K, <i>et al<\/i>: The serum- and glucocorticoid-induced kinase is a physiological mediator of aldosterone action. <i>Endocrinology<\/i> 2001; <b>142<\/b>: 1587-1594.","DOI":"10.1210\/en.142.4.1587"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000163562.82134.8E"},{"key":"26","unstructured":"26. Hall CE, Hall O: Hypertension and hypersalimentation. II. Deoxycorticosterone hypertension. <i>Lab Invest<\/i> 1965; <b>14<\/b>: 1727-1735."},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.28.447"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ma J, Weisberg A, Griffin JP, Vaughan DE, Fogo AB, Brown NJ: Plasminogen activator inhibitor-1 deficiency protects against aldosterone-induced glomerular injury. <i>Kidney Int<\/i> 2006; <b>69<\/b>: 1064-1072.","DOI":"10.1038\/sj.ki.5000201"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Ullian ME, Islam MM, Robinson CJ, Fitzgibbon WR, Tobin ET, Paul RV: Resistance to mineralocorticoids in Wistar-Furth rats. <i>Am J Physiol<\/i> 1997; <b>272<\/b>: H1454-H1461.","DOI":"10.1152\/ajpheart.1997.272.3.H1454"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-1244"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ramirez-Gil JF, Trouve P, Mougenot N, Carayon A, Lechat P, Charlemagne D: Modifications of myocardial Na<sup>+<\/sup>,K<sup>+<\/sup>-ATPase isoforms and Na<sup>+<\/sup>\/Ca<sup>2+<\/sup> exchanger in aldosterone\/salt-induced hypertension in guinea pigs. <i>Cardiovasc Res<\/i> 1998; <b>38<\/b>: 451-462.","DOI":"10.1016\/S0008-6363(98)00007-8"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M410052200"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL: High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. <i>J Clin Invest<\/i> 1994; <b>93<\/b>: 2393-2402.","DOI":"10.1172\/JCI117246"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Oliverio MI, Delnomdedieu M, Best CF, <i>et al<\/i>: Abnormal water metabolism in mice lacking the type 1A receptor for ANG II. <i>Am J Physiol Renal Physiol<\/i> 2000; <b>278<\/b>: F75-F82.","DOI":"10.1152\/ajprenal.2000.278.1.F75"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Maitland K, Bridges L, Davis WP, Loscalzo J, Pointer MA: Different effects of angiotensin receptor blockade on end-organ damage in salt-dependent and salt-independent hypertension. <i>Circulation<\/i> 2006; <b>114<\/b>: 905-911.","DOI":"10.1161\/CIRCULATIONAHA.106.622316"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Iwamoto T, Kita S, Zhang J, <i>et al<\/i>: Salt-sensitive hypertension is triggered by Ca<sup>2+<\/sup> entry <i>via<\/i> Na<sup>+<\/sup>\/Ca<sup>2+<\/sup> exchanger type-1 in vascular smooth muscle. <i>Nat Med<\/i> 2004; <b>10<\/b>: 1193-1199.","DOI":"10.1038\/nm1118"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T01:05:18Z","timestamp":1684112718000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nature.com\/doifinder\/10.1291\/hypres.30.979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1291\/hypres.30.979","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}